Press Releases

21 Jul 2023

New tumour-selective light treatment could kill breast cancer cells with greater accuracy and improve tumour control

NUS researchers introduce a new form of photodynamic therapy that can suppress secondary tumour formation without injuring surrounding tissues.

04 Jul 2023

Young cancer survivors at higher risk of depression, anxiety and other mental health disorders: NUS study

A review and analysis of 52 studies that examined over 20,000 childhood, adolescent and young adult cancer patients and survivors found that they are at an increased lifetime risk of developing depression, anxiety and mental health illnesses even after remission of cancer.

22 Jun 2023

Plant based compound Peruvoside could prevent spread of diverse medically important viruses: NUS Medicine

Researchers from NUS Medicine found that inhibiting a human protein that is essential for building the virus factories within the body, may be the answer to fighting a range of virus infections, such as SARS-CoV-2, Hand, Foot and Mouth Disease and Influenza.

08 Jun 2023

ChatGPT candidate performs well in obstetrics and gynaecology clinical examination, compared to human candidates

In a study to determine how the Chat Generative Pre-Trained Transformer or ChatGPT would fare in medical specialist examinations compared to human candidates without additional training, the Artificial Intelligence chatbot performed better than human candidates in a mock Obstetrics and Gynaecology (O&G) specialist clinical examination, used to assess the eligibility of individuals to become O&G specialists.

31 May 2023

Obesity will become the most important risk factor for heart attacks within 3 decades

Obesity is set to become the leading risk factor for acute myocardial infarction (AMI) onset, with obesity associated AMI-related deaths projected to increase by three times (294.7%) in Singapore by 2050.

31 May 2023

Understanding cognitive decline among elderly with Dementia using the “Heart-to-Brain Connection”

While investigating the relationship between cardiovascular function and brain health and cognition among the elderly at-risk for dementia in Singapore, NUS researchers found that cardiovascular dysfunction could lead to cerebrovascular dysfunction processes, which may ultimately result in dementia and cognitive decline.

06 May 2023

NUS Yong Loo Lin School of Medicine receives $6 million gift for Yeo Boon Khim Mind Science Centre

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has been gifted $6 million for the Mind Science Centre, an academic research centre under NUS Medicine, by Mr Lin Tah Hwa. The Centre will be named the Yeo Boon Khim Mind Science Centre in honor of Mr Lin's late mother, Madam Yeo Boon Khim, in gratitude of the generous gift.

26 Apr 2023

Building Resilience is Key to Good Mental Health: NUS Youth Epidemiology and Resilience Study

With data collected over the COVID-19 pandemic period from 2020 to 2022, the NUS Youth Epidemiology and Resilience (YEAR) study involved 3,336 young people aged 10 to 18 and describes the association of resilience, risks, and protective factors in developing internalising and externalising symptoms, and how resilience mitigates mental health distress.

24 Apr 2023

Red blood cell particles are effective drug carriers in suppressing muscle loss caused by cancer: NUS study

A study demonstrated that vesicles released by red blood cells are a viable platform for delivering drugs to increase muscle growth and suppress cancer-associated skeletal muscle weakening and loss.

19 Apr 2023

Digital Peer Emotional Support Improves Youth Well-being: NUS study

In a study led by the Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and digital peer support platform, Acceset, it was found that peer support via a digital platform enhanced the well-being of youth, with reduction of self-reported depression and anxiety symptoms after the intervention. Of note, digital peer support lowered depressive and anxiety symptoms in emerging adults following intervention, by nearly 40%, compared to symptoms prior to intervention. The effect of the intervention was sustained beyond the period of the intervention, for approximately six weeks.